Advances in 2D NMR Spectroscopy of Monoclonal Antibodies
Monoclonal antibodies (mAbs) represent one of the fastest growing classes of pharmaceuticals, and look set to be the focus of the biotherapeutics industry into the years to come. These proteins possess enormous potential from a drug development point-of-view as they can be engineered to recognise almost any antigen and can subsequently be mass-produced in large quantities. owever, the correct folding of mAbs is critical for their efficacy, as their structure is closely related to their function. Incorrect folding can impact safety, for instance, by inducing an unwanted immune response. Therefore, methods to quickly and accurately characterise the structure of mAbs are needed for quality control purposes. Making progress The high-resolution structural analysis of mAbs has largely been thought to be unfeasible due to the limitations of available techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. For example, the size of mAbs, at around 150 kDa,...